Endometrial stromal nodule

From Wikipedia, the free encyclopedia

SymptomsUsually asymptomatic, abnormal vaginal bleeding, pelvic mass
Usual onsetReproductive to postmenopausal age
DurationChronic, benign
Endometrial stromal nodule
Endometrial stromal nodule, histology
SpecialtyGynecology, Pathology
SymptomsUsually asymptomatic, abnormal vaginal bleeding, pelvic mass
Usual onsetReproductive to postmenopausal age
DurationChronic, benign
TypesBenign endometrial stromal tumor
CausesUnknown; associated with hypoestrogenism, tamoxifen
Risk factorsNone specific
Diagnostic methodHistopathology, immunohistochemistry (CD10+, desmin−)
Differential diagnosisLeiomyoma, Endometrial stromal sarcoma
TreatmentSurgical excision (hysterectomy or conservative)
MedicationNone specific; hormonal therapy rarely used
PrognosisExcellent after complete excision
Frequency<10% of uterine mesenchymal neoplasms
DeathsNone reported

An endometrial stromal nodule is a noninfiltrative, circumscribed proliferation of endometrial stromal cells and is a benign subtype of endometrial stromal tumor.[1] The appearance of the cells is identical to normal endometrial stromal cells. This can only be differentiated from low-grade endometrial stromal sarcoma by confirming lack of infiltration.[2] These nodules are rare and typically discovered incidentally after hysterectomy, with an excellent prognosis following complete excision.[3]

Patients are usually asymptomatic or present with abnormal vaginal bleeding or a pelvic mass.[1]

Pathology

Gross description

Well-circumscribed, nonencapsulated, soft yellow-tan mass (1–12 cm) with expansile borders.[1]

Microscopic description

Microscopically, the tumor consists of monotonous proliferations of bland endometrial stromal cells resembling proliferative-phase stroma. Characteristic findings include prominent proliferative-type arterioles, collagen bands, and an expansile (non-infiltrative) border. Invasion, if present, is limited to <3 mm and <3 tongue-like protrusions. Mitotic activity is typically low (<10/10 HPF), and angiolymphatic invasion is absent.[1]

Differential diagnosis

Treatment and prognosis

References

Related Articles

Wikiwand AI